News
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc.
TipRanks on MSN4h
Eli Lilly completes acquisition of Verve Therapeutics
Eli Lilly and Company (LLY) announced the successful completion of its acquisition of Verve Therapeutics. (VERV). Verve is a Boston-based clinical-stage company developing genetic medicines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback